InsiderTrades

Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC

Accepted 2021-09-10 00:00:00 ET · period of report 2021-08-02 · accession 0001209191-21-055478 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2021-09-10 2021-08-02+ CPIX Cearnal Martin E SVP, Chief Commercial Off, Dir P - Purchase $2.98 +2,205 168.2K +1% +$6,567

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-08-16 P A 105 $2.92 168,309 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
2 Common Common Stock 2021-08-17 P A 105 $3.05 168,414 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
3 Common Common Stock 2021-08-18 P A 105 $2.97 168,519 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
4 Common Common Stock 2021-08-19 P A 105 $3.02 168,624 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
5 Common Common Stock 2021-08-20 P A 105 $2.96 168,729 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
6 Common Common Stock 2021-08-23 P A 105 $2.87 168,834 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
7 Common Common Stock 2021-08-24 P A 105 $2.89 168,939 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
8 Common Common Stock 2021-08-25 P A 105 $2.79 169,044 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
9 Common Common Stock 2021-08-26 P A 105 $2.82 169,149 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
10 Common Common Stock 2021-08-27 P A 105 $2.84 169,254 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
11 Common Common Stock 2021-08-30 P A 105 $2.88 169,359 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
12 Common Common Stock 2021-08-31 P A 105 $2.93 169,464 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
13 Common Common Stock 2021-08-02 P A 105 $3.34 167,364 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
14 Common Common Stock 2021-08-03 P A 105 $3.17 167,469 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
15 Common Common Stock 2021-08-04 P A 105 $3.18 167,574 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
16 Common Common Stock 2021-08-05 P A 105 $3.11 167,679 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
17 Common Common Stock 2021-08-06 P A 105 $3.01 167,784 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
18 Common Common Stock 2021-08-09 P A 105 $2.93 167,889 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
19 Common Common Stock 2021-08-10 P A 105 $2.96 167,994 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
20 Common Common Stock 2021-08-11 P A 105 $2.98 168,099 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
21 Common Common Stock 2021-08-13 P A 105 $2.92 168,204 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.